The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
Rethinking evidence generation for ultra-rare diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the inherent limitations of traditional…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
Rethinking Artificial Intelligence in Cognitive Science as New Research Challenges the Centaur Model
The intersection of cognitive psychology and artificial intelligence has long been a frontier of scientific inquiry, driven by the ambition…
Read More
Rethinking Metabolic Control: How Astrocytes and Tanycytes Drive Brain Signaling for Hunger and Satiety
For decades, the scientific understanding of how the human brain regulates appetite has been almost exclusively focused on the activity…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
Developing effective treatments for ultra-rare diseases has long presented a profound paradox for the biopharmaceutical industry and regulatory bodies. While…
Read More
Rethinking Tribology: Researchers Discover Contactless Magnetic Friction and the Breakdown of Amontons Law
In a discovery that challenges three centuries of physical principles, researchers at the University of Konstanz have identified a novel…
Read More
